Erectile Dysfunction in Young Myocardial Infarction Survivors: Evaluation, Follow Up.
Gabriela Dostálová, Zuzana Hlubocká, Kristýna Bayerová...
https://pubmed.ncbi.nlm.nih.gov/28697641Actively Recruiting
Age: 30Years - 75Years
MALE
Healthy Volunteers
ID07444697
Erectile Function After Percutaneous Coronary Intervention in Myocardial Infarction and Non-Infarction Patients: A Prospective Comparative Study
Led by Kırıkkale University · Updated on 2026-03-03
100
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are evaluating erectile function changes in male patients who undergo percutaneous coronary intervention (PCI) for either a heart attack or stable angina. The study aims to understand how myocardial infarction affects erectile function over time and to explore whether erectile dysfunction can predict future cardiac events. This observational study compares erectile function between patients with myocardial infarction and those with stable angina using standardized questionnaires. Participants are grouped into two sets: those treated with PCI after a heart attack and those treated due to stable angina. Erectile function is assessed at baseline (after recovery from PCI), and at 3 and 6 months post-procedure using the International Index of Erectile Function (IIEF) questionnaire. Additional assessments include the Beck Depression Inventory and Fear of Cardiac Recurrence and Progression Scale. Researchers also collect clinical data such as cardiac vessel scores, ejection fraction, testosterone levels, body measurements, medication use, and the intervention method. During the study, male participants aged 30 to 75 will complete face-to-face interviews and questionnaires at specified intervals: baseline, 3 months, and 6 months after PCI. The study measures changes in erectile function scores over time and examines associations with cardiac health, depression, and anxiety symptoms. Safety and participation are monitored throughout the follow-up period. The total duration of involvement is up to 6 months, with evaluations focusing on erectile function and related health parameters.
CONDITIONS
Brief Title
"Erectile Function After PCI in MI and Non-MI Patients"
Who Can Participate
Age: 30Years - 75Years
MALE
Healthy Volunteers
Eligibility Criteria
You may qualify if you...
- Male patients aged 30 to 75 years
- Undergoing successful percutaneous coronary intervention (PCI) for acute myocardial infarction or stable angina
- Hemodynamically stable after the PCI procedure
- Survived the initial hospitalization
- Able to provide written informed consent
- Sexually active within the 3 months prior to enrollment
- Willing and able to complete follow-up visits and questionnaires at baseline, 3 months, and 6 months
You will not qualify if you...
- Known active or recently treated malignancy
- Neurological disorders affecting erectile function such as spinal cord injury, multiple sclerosis, or Parkinson's disease
- Uncontrolled diabetes mellitus with HbA1c over 9%
- More than two chronic systemic diseases including severe kidney, liver, or lung disease
- Chronic use of more than three daily medications (polypharmacy)
- Absence of sexual activity or lack of a sexual partner
- Refusal or inability to provide informed consent or complete study questionnaires
- Severe psychiatric illness interfering with participation
- Untreated endocrine disorders including hypogonadism or thyroid disease
- Major post-PCI complications preventing participation such as reinfarction, stroke, or heart failure
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
1
2
3
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Monitoring
Duration - 6 months
Participants who have undergone successful percutaneous coronary intervention (PCI) are observed to assess erectile function and related factors over time.
3 visits (baseline, 3 months, and 6 months; face-to-face interviews in clinical environment)
Trial Site Locations
Total: 1 location
1
The Hospital of Kirikkale Univerity Faculty of Medicine
Kirikkale, Turkey (Türkiye), 71450
Actively Recruiting
Loading map...
Research Team
T
Timucin Sipal, MD, PhD
C
Caglar Alp, MD, PhD
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Published Research Related To This Trial
Effect of myocardial infarction on the occurrence of erectile dysfunction.
Enisa Hodžić, Adnan Durek, Edin Begić...
https://pubmed.ncbi.nlm.nih.gov/30589239Is the History of Erectile Dysfunction a Reliable Risk Factor for New Onset Acute Myocardial Infarction? A Systematic Review and Meta-Analysis.
Ahmed Adam, Jared McDowall, Sunday Joseph Aigbodion...
https://pubmed.ncbi.nlm.nih.gov/33224004Protocol for the development and validation of a clinical measurement tool for fear of disease progression and recurrence in cardiac patients.
Sarah T Clarke, Michael Le Grande, Barbara M Murphy...
https://pubmed.ncbi.nlm.nih.gov/39027197Distress: associated variables of erectile dysfunction post-acute myocardial infarction. A pilot study.
L Vacanti, B Caramelli
https://pubmed.ncbi.nlm.nih.gov/15538397Association between erectile dysfunction and coronary artery disease: Matching the right target with the right test in the right patient.
Piero Montorsi, Paolo M Ravagnani, Stefano Galli...
https://pubmed.ncbi.nlm.nih.gov/16901623Effect of PCI on quality of life in patients with stable coronary disease.
William S Weintraub, John A Spertus, Paul Kolm...
https://pubmed.ncbi.nlm.nih.gov/18703470